Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 4
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Stevenson, Jennifer Parekh, Nikesh Ali, Khalid Timeyin, Jean Bremner, Stephen Van Der Cammen, Tischa Allen, Jane Schiff, Rebekah Harchowal, Jatinder Davies, Graham and Rajkumar, Chakravarthi 2016. Protocol for a Prospective (P) study to develop a model to stratify the risk (RI) of medication (M) related harm in hospitalized elderly (E) patients in the UK (The PRIME study). BMC Geriatrics, Vol. 16, Issue. 1,


    Price, Sylvie D. Holman, C. D’Arcy J. Sanfilippo, Frank M. and Emery, Jon D. 2014. Impact of Specific Beers Criteria Medications on Associations between Drug Exposure and Unplanned Hospitalisation in Elderly Patients Taking High-Risk Drugs: A Case-Time-Control Study in Western Australia. Drugs & Aging, Vol. 31, Issue. 4, p. 311.


    Price, Sylvie D. Holman, C. D'Arcy J. Sanfilippo, Frank M. and Emery, Jon D. 2013. Use of case-time-control design in pharmacovigilance applications: exploration with high-risk medications and unplanned hospital admissions in the Western Australian elderly. Pharmacoepidemiology and Drug Safety, Vol. 22, Issue. 11, p. 1159.


    Marcum, Zachary A. Amuan, Megan E. Hanlon, Joseph T. Aspinall, Sherrie L. Handler, Steven M. Ruby, Christine M. and Pugh, Mary Jo V. 2012. Prevalence of Unplanned Hospitalizations Caused by Adverse Drug Reactions in Older Veterans. Journal of the American Geriatrics Society, Vol. 60, Issue. 1, p. 34.


    ×

Adverse drug reactions in older people

  • B Tangiisuran (a1), MP Gozzoli (a2), JG Davies (a3) and C Rajkumar (a1)
  • DOI: http://dx.doi.org/10.1017/S0959259810000171
  • Published online: 14 June 2010
Abstract
Summary

Adverse drug reactions (ADR) pose significant health-related problems for the older person. Many studies from around the world report a significant incidence of ADR in general and in elderly people in particular, resulting in an increase in drug-related morbidity and mortality. Older people appear to be particularly at risk of experiencing an ADR due to a range of factors, which include polypharmacy, altered drug pharmacokinetic profiles and pharmacodynamic responses, drug interactions and cognitive problems that increase the risk in this patient group. Certain drug classes, such as hypoglycaemic agents and cardiovascular active medicines, have been identified as common causes of ADR. Many studies suggest that the majority of ADR are preventable, so that several different approaches have been tried in an attempt to limit this problem, such as the use of computerized systems to communicate routine issues of patient care, interventions made by pharmacists, spontaneous reporting and continuous education of health care professionals. Whilst all have been shown to reduce drug-related events, identifying individuals at high risk of developing ADR at the point of prescribing by using a risk stratification model could improve the identification and prevention of ADR. This article discusses the clinical impact of ADR in older people and the relative merits of the various approaches tested to date before suggesting areas that require further research.

Copyright
Corresponding author
Address for correspondence: Dr Balamurugan Tangiisuran, Department of Medicine, Brighton and Sussex Medical School, University of Sussex, Falmer, UK. Email: b.tangiisuran@bsms.ac.uk
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

2E Lenaghan , R Holland , A Brooks . Home-based medication review in a high risk elderly population in primary care – the POLYMED randomised controlled trial. Age Ageing 2007; 36: 292–97.

3CJ Lowe , DK Raynor , J Purvis , A Farrin , J Hudson . Effects of a medicine review and education programme for older people in general practice. Br J Clin Pharmacol 2000; 50: 172–75.

4DW Bates , DJ Cullen , N Laird , LA Petersen , SD Small , D Servi Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995; 274: 2934.

5JR Nebeker , P Barach , MH Samore . Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med 2004; 140: 795801.

7IR Edwards , JK Aronson . Adverse drug reactions: definitions, diagnosis and management. Lancet 2000; 356: 1255–59.

8EC Davies , CF Green , S Taylor , PR Williamson , DR Mottram , M Pirmohamed . Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS ONE 2009; 4: e4439.

9EC Davies , CF Green , DR Mottram , M Pirmohamed . Adverse drug reactions in hospital in-patients: a pilot study. J Clin Pharm Ther 2006; 31: 335–41.

10M Pirmohamed , S James , S Meakin , C Green , AK Scott , TJ Walley Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ 2004; 329: 1519.

12JK Aronson , RE Ferner . Joining the DoTS: new approach to classifying adverse drug reactions. BMJ 2003; 327: 1222–25.

13MK Rommers , IM Teepe-Twiss , HJ Guchelaar . Preventing adverse drug events in hospital practice: an overview. Pharmacoepidemiol Drug Safety 2007; 16: 1129–35.

14LL Leape , TA Brennan , N Laird , AG Lawthers , AR Localio , BA Barnes The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. NEJM 1991; 324: 377–84.

16HJ Beijer , de CJ Blaey . Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002; 24: 4654.

17JH Gurwitz , TS Field , LR Harrold , J Rothschild , K Debellis , AC Seger Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289: 1107–16.

19M Chan , F Nicklason , JH Vial . Adverse drug events as a cause of hospital admission in the elderly. Int Med J 2001; 31: 199205.

20J Hallas , T Haghfelt , LF Gram , E Grodum , N Damsbo . Drug related admissions to a cardiology department; frequency and avoidability. J Int Med 1990; 228: 379–84.

21G Cunningham , TRP Dodd , DJ Grant , MET McMurdo , R Michael , E Richards . Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. Age Ageing 1997; 26: 375–82.

24RL Page 2nd, JM Ruscin . The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. Am J Geriatr Pharmcother 2006; 4: 297305.

26EC Davies , CF Green , DR Mottram , M Pirmohamed . Adverse drug reactions in hospitals: a narrative review. Current Drug Safety 2007; 2: 7987.

27LG Seidl , GF Thornton , LE Cluff . Epidemiological studies of adverse drug reactions. Am J Pub Health 1965; 55: 1170–75.

28N Hurwitz , OL Wade . Intensive hospital monitoring of adverse reactions to drugs. BMJ 1969; 1: 531–36.

29CC Smith , PM Bennett , HM Pearce , PI Harrison , DJ Reynolds , JK Aronson Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol 1996; 42: 423–29.

31DJ van Kraaij , CJ Haagsma , IH Go , FW Gribnau . Drug use and adverse drug reactions in 105 elderly patients admitted to a general medical ward. Netherland J Med 1994; 44: 166–73.

32CM Hohl , J Dankoff , A Colacone , M Afilalo . Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 2001; 38: 666–71.

33CM Lindley , MP Tully , V Paramsothy , RC Tallis . Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992; 21: 294300.

34CK Mannesse , FH Derkx , MA de Ridder , AJ Man in't Veld , TJ Van Der Cammen . Adverse drug reactions in elderly patients as a contributing factor for hospital admission: cross sectional study. BMJ 1997; 315: 1057–58.

35J Lazarou , BH Pomeranz , PN Corey . Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200–5.

36K Wester , AK Jonsson , O Spigset , H Druid , S Hagg . Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol 2008; 65: 573–79.

38I Buajordet , J Ebbesen , J Erikssen , O Brors , T Hilberg . Fatal adverse drug events: the paradox of drug treatment. J Int Med 2001; 250: 327–41.

39DC Classen , SL Pestotnik , RS Evans , JF Lloyd , JP Burke . Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997; 277: 3036.

40DW Bates , N Spell , DJ Cullen , E Burdick , N Laird , LA Petersen The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997; 277: 307–11.

41JM Rothschild , FA Federico , TK Gandhi , R Kaushal , DH Williams , DW Bates . Analysis of medication-related malpractice claims: causes, preventability, and costs. Arch Int Med 2002; 162: 2414–20.

42ES El Desoky . Pharmacokinetic-pharmacodynamic crisis in the elderly. Am J Ther 2007; 14: 488–98.

43B Tangiisuran , J Wright , T Van Der Cammen , C Rajkumar . Adverse drug reactions in elderly: challenges in identification and improving preventative strategies. Age Ageing 2009; 38: 358–59.

44AA Mangoni , SHD Jackson . Age-related changes in pharmacokinetics and pharmacodynamics: Basic principles and practical applications. Br J Clin Pharmacol 2003; 57: 614.

46J Zeeh , D Platt . The aging liver: structural and functional changes and their consequences for drug treatment in old age. Gerontology 2002; 48: 121–27.

49TS Field , JH Gurwitz , J Avorn , D McCormick , S Jain , M Eckler Risk factors for adverse drug events among nursing home residents. Arch Int Med 2001; 161: 1629–34.

50JK Nguyen , MM Fouts , SE Kotabe , E Lo . Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother 2006; 4: 3641.

51LJ Veehof , RE Stewart , B Meyboom-de Jong , FM Haaijer-Ruskamp . Adverse drug reactions and polypharmacy in the elderly in general practice. Eur J Clin Pharmacol 1999; 55: 533–36.

52G Onder , C Pedone , F Landi , M Cesari , Della C Vedova , R Bernabei Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). JAGS 2002; 50: 1962–68.

53Y Zopf , C Rabe , A Neubert , EG Hahn , H Dormann . Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals. Drug Saf 2008; 31: 789–98.

54PM van den Bemt , AC Egberts , AW Lenderink , JM Verzijl , KA Simons , WS van der Pol Risk factors for the development of adverse drug events in hospitalized patients. Pharm World Sci 2000; 22: 6266.

56SE Campbell , DG Seymour , WR Primrose . A systematic literature review of factors affecting outcome in older medical patients admitted to hospital. Age Ageing 2004; 33: 110–15.

57A Kennerfalk , A Ruigomez , MA Wallander , L Wilhelmsen , S Johansson . Geriatric drug therapy and healthcare utilization in the United kingdom. Ann Pharmacother 2002; 36: 797803.

58NS Beckett , R Peters , AE Fletcher , JA Staessen , L Liu , D Dumitrascu Treatment of hypertension in patients 80 years of age or older. NEJM 2008; 358: 1887–98.

59DN Juurlink , M Mamdani , A Kopp , A Laupacis , DA Redelmeier . Drug–drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003; 289: 1652–58.

60DN Juurlink , MM Mamdani , A Kopp , PA Rochon , KI Shulman , DA Redelmeier . Drug-induced lithium toxicity in the elderly: a population-based study. JAGS 2004; 52: 794–98.

61AM Holbrook , JA Pereira , R Labiris , H McDonald , JD Douketis , M Crowther Systematic overview of warfarin and its drug and food interactions. Arch Int Med 2005; 165: 1095–106.

62PA Rochon , JH Gurwitz . Optimising drug treatment for elderly people: the prescribing cascade. BMJ 1997; 315: 1096–99.

63HJ Hamilton , PF Gallagher , D O'Mahony . Inappropriate prescribing and adverse drug events in older people. BMC Geriatr 2009; 9: 5.

64ER Hajjar , JT Hanlon , RJ Sloane , CI Lindblad , CF Pieper , CM Ruby Unnecessary drug use in frail older people at hospital discharge. JAGS 2005; 53: 1518–23.

66JC McElnay , CR McCallion , F Al-Deagi , MG Scott . Development of a risk model for adverse drug events in the elderly. Clin Drug Invest 1997; 13: 4755.

67L Bowman , BC Carlstedt , EF Hancock , CD Black . Adverse drug reaction (ADR) occurrence and evaluation in elderly inpatients. Pharmacoepidemiol Drug Safety 1996; 5: 918.

68BJ Vakil , RD Kulkarni , NL Chabria , DR Chadha , VA Deshpande . Intense surveillance of adverse drug reactions. An analysis of 338 patients. J Clin Pharmacol 1975; 15: 435–41.

69ER Hajjar , JT Hanlon , MB Artz , CI Lindblad , CF Pieper , RJ Sloane Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacol 2003; 1: 8289.

70JL Green , JN Hawley , KJ Rask . Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? Am J Geriatr Pharmacother 2007; 5: 3139.

71H Ganjavi , N Herrmann , PA Rochon , P Sharma , M Lee , D Cassel Adverse drug events in cognitively impaired elderly patients. Dem Geriatr Cog Disord 2007; 23: 395400.

72G Onder , G Gambassi , CJ Scales , M Cesari , CD Vedova , F Landi Adverse drug reactions and cognitive function among hospitalized older adults. Eur J Clin Pharmacol 2002; 58: 371–77.

74CK Mannesse , FH Derkx , MA de Ridder , AJ Man in't Veld , TJ Van Der Cammen . Do older hospital patients recognize adverse drug reactions? Age Ageing 2000; 29: 7981.

75RL Howard , AJ Avery , S Slavenburg , S Royal , G Pipe , P Lucassen Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007; 63: 136–47.

76J. Reason Human error: models and management. BMJ 2000; 320: 768–70.

78LL Leape , DW Bates , DJ Cullen , J Cooper , HJ Demonaco , T Gallivan Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA 1995; 274: 3543.

79R Kaushal , KG Shojania , DW Bates . Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Int Med 2003; 163: 1409–16.

80DW Bates , LL Leape , DJ Cullen , N Laird , LA Petersen , JM Teich Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998; 280: 1311–16.

81SN Kucukarslan , M Peters , M Mlynarek , DA Nafziger . Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Int Med 2003; 163: 2014–18.

82R Holland , J Desborough , L Goodyer , S Hall , D Wright , YK Loke . Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol 2008; 65: 303–16.

83U Gillespie , A Alassaad , D Henrohn , H Garmo , M Hammarlund-Udenaes , H Toss A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Int Med 2009; 169: 894900.

84KE Schmader , JT Hanlon , CF Pieper , R Sloane , CM Ruby , J Twersky Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 2004; 116: 394401.

85F Andersohn , S Suissa , E Garbe . Use of first- and second-generation cyclooxygenase-2-selective non-steroidal antiinflammatory drugs and risk of acute myocardial infarction. Circulation 2006; 113: 1950–57.

86CR Ayers , JT Sorrell , SR Thorp , JL Wetherell . Evidence-based psychological treatments for late-life anxiety. Psychology Aging 2007; 22: 817.

87UA Meyer . Pharmacogenetics and adverse drug reactions. Lancet 2000; 356: 1667–71.

88CJ Ross , H Katzov , B Carleton , MR Hayden . Pharmacogenomics and its implications for autoimmune disease. J Autoimmun 2007; 28: 122–28.

89E Steyerberg . Clinical Prediction Models: A practical approach to development, validation, and updating. MKK Gail , J Samet , A Tsiatis , W Wong (eds). Rotterdam: Springer; 2009.

90JH Wasson , HC Sox , RK Neff , L Goldman . Clinical prediction rules. Applications and methodological standards. NEJM 1985; 313: 793–99.

91PE Johnston , DJ France , DW Byrne , HJ Murff , B Lee , RA Stiles Assessment of adverse drug events among patients in a tertiary care medical center. Am J Health Syst Pharm 2006; 63: 2218–27.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Reviews in Clinical Gerontology
  • ISSN: 0959-2598
  • EISSN: 1469-9036
  • URL: /core/journals/reviews-in-clinical-gerontology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords: